| Richard A. Miller, M.D. | President and Chief Executive Officer | FY2025 | |
| Leiv Lea | Chief Financial Officer | FY2025 | |
| William B. Jones, Ph.D. | Senior Vice President, Pharmaceutical Development | FY2025 |
3 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.